Abstract
Abstract
Background
Eswatini faces persistent challenges in providing care for diabetes and hypertension, exacerbated by a shortage of healthcare workers. The implementation of WHO-PEN interventions aimed to address these issues, yet their effects on healthcare worker time requirements and associated costs remain unclear.
Methods
This study employed a time-and-motion analysis and a bottom-up cost assessment to quantify the human and financial resources required for scaling up WHO-PEN interventions nationally in Eswatini for all estimated diabetic and hypertensive patients.
Results
Findings reveal that healthcare workers in intervention-arm clinics reported longer workday durations compared to those in control-arm clinics, yet spent less time per patient while seeing more patients. The implementation of WHO-PEN interventions increased the workload on healthcare workers but also led to a notable increase in patient care utilization. Furthermore, a morning peak in patient visits was identified, suggesting potential opportunities for optimizing patient flow. Notably, scaling up care provision nationally with WHO-PEN interventions proved to be more cost saving than expanding standard-of-care treatment.
Conclusion
WHO-PEN interventions hold promise in improving access to diabetes and hypertension care in Eswatini while offering an efficient solution. However, addressing challenges in healthcare workforce creation and retention is crucial for sustained effectiveness. Policy makers must consider all aspects of the WHO-PEN intervention for informed decision-making.
Trial registration US Clinical Trials Registry. NCT04183413. Trial registration date: December 3, 2019. https://ichgcp.net/clinical-trials-registry/NCT04183413
Funder
HORIZON EUROPE Framework Programme
University of Basel
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Ansari-Moghaddam A, Setoodehzadeh F, Khammarnia M, et al. Economic cost of diabetes in the Eastern Mediterranean region countries: a meta-analysis. Diabetes Metab Syndr Clin Res Rev. 2020;14(5):1101–8. https://doi.org/10.1016/j.dsx.2020.06.044. (ISSN 1871-4021).
2. Basu S, Wagner RG, Sewpaul R, Reddy P, Davies J. Implications of scaling up cardiovascular disease treatment in South Africa: a microsimulation and cost-effectiveness analysis. Lancet Glob Health. 2019;7(2):e270–80. https://doi.org/10.1016/S2214-109X(18)30450-9.
3. Eswatini Ministry of Health. WHO STEPS Non-communicable disease risk factor surveillance report, Swaziland. Geneva: WHO Press; 2014. https://extranet.who.int/ncdsmicrodata/index.php/catalog/688/related-materials. Accessed 13 Dec 2023.
4. Government of the Kingdom of Eswatini. Budget Estimates 2022–23; 2022. https://www.gov.sz/index.php/budget-monetary-affairs/budget-estimates. Accessed 23 Nov 2023.
5. Gnugesser E, Chwila C, Brenner S, et al. The economic burden of treating uncomplicated hypertension in Sub-Saharan Africa: a systematic literature review. BMC Public Health. 2022;22:1507. https://doi.org/10.1186/s12889-022-13877-4.